- ISIN
- US3159182431
- Issuer
- Fidelity
- Inception Date
- Oct 2, 2018
- Category
- Health & Biotech Equities
- Min. Investment
- $0
- Distribution Policy
- Distributing
- Asset Class
- Equity
- Asset Class Size
- Mid-Cap
- Asset Class Style
- Growth
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
FIJYX Performance Chart
Fidelity Advisor Biotechnology Fund Class Z (FIJYX) is up 6.8% since the beginning of the year. FIJYX is currently trading at $44 per share. Investors who bought $1,000 worth of FIJYX shares 5 years ago would now be looking at an investment worth $1,522.
Loading charts...
Returns By Period
Fidelity Advisor Biotechnology Fund Class Z (FIJYX) has returned 6.75% so far this year and 56.44% over the past 12 months.
Fidelity Advisor Biotechnology Fund Class Z
- 1D
- 0.02%
- 1M
- 2.89%
- YTD
- 6.75%
- 6M
- 3.92%
- 1Y
- 56.44%
- 3Y*
- 17.66%
- 5Y*
- 8.77%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
FIJYX Monthly Returns History
Based on dividend-adjusted daily data since Oct 17, 2018, FIJYX's average daily return is +0.05%, while the average monthly return is +1.04%. At this rate, an investment would double in approximately 5.6 years.
Historically, 63% of months were positive and 37% were negative. The best month was Dec 2023 with a return of +19.5%, while the worst month was Dec 2024 at -13.6%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 3 months.
On a daily basis, FIJYX closed higher 51% of trading days. The best single day was Mar 13, 2020 with a return of +7.5%, while the worst single day was Mar 16, 2020 at -11.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 1.43% | 2.19% | -1.26% | 2.08% | 0.58% | 1.59% | 6.75% | ||||||
| 2025 | 1.00% | -0.60% | -5.12% | 0.60% | -3.14% | 3.64% | 8.13% | 5.94% | 10.95% | 8.58% | 10.67% | -4.65% | 40.09% |
| 2024 | 4.24% | 6.57% | 1.96% | -8.91% | 1.72% | 4.52% | 7.89% | 3.11% | 0.55% | 0.49% | -6.13% | -13.57% | 0.03% |
| 2023 | 1.17% | -3.54% | -2.28% | 3.30% | 0.33% | 0.52% | 2.28% | -2.95% | -4.08% | -5.64% | 4.22% | 19.53% | 11.19% |
| 2022 | -12.73% | 0.31% | 4.86% | -13.09% | -6.14% | 5.55% | 2.69% | 8.53% | -1.92% | 5.51% | 1.70% | -0.33% | -7.60% |
| 2021 | 0.58% | 0.65% | -4.66% | 1.42% | -4.85% | 5.57% | -1.80% | 8.67% | -5.04% | 1.24% | -6.25% | 2.81% | -2.76% |
Benchmark Metrics
Fidelity Advisor Biotechnology Fund Class Z has an annualized alpha of 1.16%, beta of 0.84, and R2 of 0.44 versus S&P 500 Index. Calculated based on daily prices since October 17, 2018.
- This fund participated in 85.39% of S&P 500 Index downside but only 77.79% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.44 means the benchmark explains less than half of this fund's behavior - treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- 1.16%
- Beta
- 0.84
- R²
- 0.44
- Upside Capture
- 77.79%
- Downside Capture
- 85.39%
Expense Ratio
FIJYX has an expense ratio of 0.61%, placing it in the medium range.
Return for Risk
Risk / Return Rank
FIJYX ranks 83 for risk / return — in the top 83% of mutual funds on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Fidelity Advisor Biotechnology Fund Class Z (FIJYX) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| FIJYX | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.49 | ||
| Sortino ratioReturn per unit of downside risk | +0.60 | ||
| Omega ratioGain probability vs. loss probability | 1.40 | 1.37 | +0.03 |
| Calmar ratioReturn relative to maximum drawdown | 6.42 | 2.78 | +3.63 |
| Martin ratioReturn relative to average drawdown | 17.74 | 12.44 | +5.30 |
Dividends
Dividend History
Fidelity Advisor Biotechnology Fund Class Z provided a 1.35% dividend yield over the last twelve months, with an annual payout of $0.60 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.60 | $0.60 | $0.00 | $0.47 | $0.00 | $5.60 | $2.96 | $1.93 | $0.59 |
Dividend yield | 1.35% | 1.44% | 0.00% | 1.55% | 0.00% | 18.90% | 8.13% | 6.49% | 2.35% |
Monthly Dividends
The table displays the monthly dividend distributions for Fidelity Advisor Biotechnology Fund Class Z. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.60 | $0.60 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.47 | $0.47 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.00 | $0.00 | $5.44 | $5.60 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Fidelity Advisor Biotechnology Fund Class Z. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Fidelity Advisor Biotechnology Fund Class Z was 38.53%, occurring on Jun 13, 2022. Recovery took 427 trading sessions.
The current Fidelity Advisor Biotechnology Fund Class Z drawdown is 2.06%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
Bear market2022 | -38.53%Jun 2022 | 1y 4mo | 1y 8mo | 3y 17dFeb 2021 - Feb 2024 |
2025 selloff2025 | -36.39%Apr 2025 | 4mo 28d | 6mo 4d | 11mo 2dNov 2024 - Oct 2025 |
COVID crash2020 | -25.65%Mar 2020 | 1mo 2d | 1mo 12d | 2mo 14dFeb 2020 - Apr 2020 |
Rate-hike selloffLate 2018 | -18.59%Dec 2018 | 2mo 7d | 2mo 3d | 4mo 10dOct 2018 - Feb 2019 |
2019 correction2019 | -14.39%Oct 2019 | 5mo 27d | 1mo 18d | 7mo 15dApr 2019 - Nov 2019 |
Drawdown Indicators
| FIJYX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.53% | -56.78% | +18.25% |
Max Drawdown (1Y)Largest decline over 1 year | -8.88% | -9.10% | +0.22% |
Max Drawdown (3Y)Largest decline over 3 years | -36.39% | -18.90% | -17.49% |
Max Drawdown (5Y)Largest decline over 5 years | -36.39% | -25.43% | -10.96% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -2.06% | -1.80% | -0.26% |
Average DrawdownAverage peak-to-trough decline | -11.52% | -10.71% | -0.81% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.20% | 2.03% | +1.17% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Build a portfolio with FIJYX
Add Fidelity Advisor Biotechnology Fund Class Z to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with FIJYX